jondoeuk's latest activity

Triple Hair (Canada) began Phase 3 clinical trials for its Therapy-07 (THO7) topical in Vancouver, Canada, It contains minoxidil...

See my reply to coco_304

Pyrilutamide (KX-826) is sold directly to consumers as a cosmetic under the brand name Koshine ahead of completing approval. You can buy...

Per Kintor's latest pipeline page modification, pyrilutamide has entered the new drug application stage in China. If the application is...

Kintor plans to initiate the phase IIb/III clinical trial of GT20029 for male androgenetic alopecia in China this year.

The randomised, double-blind, placebo-controlled phase two clinical trial was published. It entailed 180 Chinese adult males with...

GT20029 is an androgen receptor degrader (AR Degrader). It was developed using a proprietary Proteolysis Targeting Chimera (PROTAC)...

0.5% BID (i.e. twice a day)

Pelage sent out an email: ''We are excited to provide a brief update on the clinical trials you signed up to hear about through our...

Currently, the company is actively advancing the marketing authorisation application for KX-826 in China.

It works https://www.hairlosstalk.com/interact/threads/pyrilutamide-kx-826-1-0-and-0-5.139682/

From Kintor Pharma: ''KT-215 is a topical MPC inhibitor under development by the Company. It activates hair follicle stem cells for Androgenetic Alopecia...

Estradiol works wonders! DHT blockers are ineffective!

''In the treatment of androgenetic alopecia, the action mechanism of 17α-estradiol is to suppress 5α-reductase activity, which impedes...

Alfatradiol is used topically and could be cheaper.